Researchers conducted a systematic review and meta-analysis for studies of acute myeloid leukemia patients with a median age less than 70 treated with HMA plus venetoclax.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/venetoclax-combo-shows-promise-younger-patients-aml-2026a1000ahk?src=rss
Author :
Publish date : 2026-04-07 08:32:00
Copyright for syndicated content belongs to the linked Source.